Side-by-side comparison

NVS vs SNY — Side-by-side comparison

Neither screens cheaper on EV/FCF, Neither has the higher ROIC, Neither has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.

NVS

Novartis AG

Price

$152.01

Market cap

$223.3B

Day %

N/A

SNY

Sanofi Aventis

Price

$44.29

Market cap

$133.3B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best
NVS
Target
Novartis AG$223.3BN/AN/AN/AN/AN/AN/AN/AN/A
SNYSanofi Aventis$133.3BN/AN/AN/AN/AN/AN/AN/AN/A

NVS implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

N/A

SNY implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

N/A

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for NVS.

Grade F
0
/ 100
Quality Radar0 – 20 per axis

Quality Scorecard

Build-time composite score for SNY.

Grade F
0
/ 100
Quality Radar0 – 20 per axis